DexCom (DXCM) operating cash flow was $1.4B in FY2025 (+46% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2025
$1.4B
+46%
2024
$990M
+32%
2023
$748M
+12%
2022
$670M
+51%
2021
$442M
-7%
2020
$476M
+51%
2019
$314M
+155%
2018
$123M
+34%
2017
$92M
+64%
2016
$56M
+15%
2015
$49M
+108%
2014
$24M
+883%
2013
$2M
+107%
2012
-$33M
-10%
2011
-$30M
+30%
2010
-$43M
-8%
2009
-$39M
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q1 2026
$526M
Q4 2025
$294M
Q3 2025
$660M
Q2 2025
$303M
Q1 2025
$184M
Q4 2024
$301M
Q3 2024
$200M
Q2 2024
$279M
Q1 2024
$209M
Q4 2023
$134M
Q3 2023
$269M
Q2 2023
$190M
Source: DXCM on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.